Synthetic Patient Health Trajectories
This dataset provides comprehensive, longitudinal synthetic patient records simulating chronic disease progression, including demographics, clinical encounters, vital signs, laboratory results, medications, and outcomes. Designed for safe AI/ML experimentation, it enables time-series modeling, predictive analytics, and healthcare research without patient privacy risks.
Sample rows
preview · 8 of 200 rows · all 27 columns| patient_idstring | encounter_typestring | vital_sign_oxygen_saturationfloat | racestring | genderstring | birth_datedate | ethnicitystring | chronic_conditionstring | diagnosis_datedate | encounter_idstring | encounter_datedatetime | provider_idstring | visit_reasonstring | vital_sign_heart_ratefloat | vital_sign_systolic_bpfloat | vital_sign_diastolic_bpfloat | vital_sign_temperaturefloat | vital_sign_respiratory_ratefloat | lab_test_namestring | lab_test_valuefloat | lab_test_unitstring | medication_namestring | medication_dosestring | medication_routestring | outcome_eventstring | outcome_datedate | notesstring |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H4Q7T9ZC | outpatient | 97 | White | female | 1950-04-13 | Not Hispanic or Latino | Alzheimer's disease | 2013-11-22 | ENCOUNTER1001 | 2023-03-14T09:34:00 | PROV1023 | Memory loss evaluation | 71 | 122 | 74 | 36.5 | 16 | Hemoglobin A1c | 5.4 | % | Donepezil | 10 mg | oral | blank | blank | Patient presented with ongoing memory decline, stable on current medication, no acute events. |
| BD2W8R3L | outpatient | 98 | Black or African American | male | 1996-07-22 | blank | Type 1 diabetes mellitus | 2005-09-01 | ENCOUNTER1002 | 2023-01-31T13:12:00 | PROV1040 | Routine diabetes follow-up | 83 | 118 | 75 | 36.7 | 18 | Blood glucose | 116 | mg/dL | Insulin glargine | 22 units | subcutaneous | blank | blank | Blood glucose levels well controlled. No episodes of hypoglycemia. Continues on insulin therapy. |
| QZ8TM4KN | inpatient | 96 | blank | female | 2009-02-18 | blank | Congenital heart defect | 2009-03-10 | ENCOUNTER1003 | 2023-02-08T10:44:00 | blank | Surgical follow-up | 104 | 93 | 56 | 36.4 | 24 | BNP | 220 | pg/mL | Furosemide | 20 mg | IV | hospitalization | 2023-02-10 | Post-surgical monitoring for congenital heart defect repair, stable hemodynamics, on diuretic therapy. |
| LJ3Y5TUN | emergency | 80 | Asian | male | 1947-11-04 | Hispanic or Latino | Chronic obstructive pulmonary disease | 2008-05-15 | ENCOUNTER1004 | 2023-03-18T15:27:00 | PROV1005 | Acute respiratory distress | 128 | 143 | 86 | 37.2 | 34 | Arterial blood gas | 7.25 | pH | Albuterol | 2 puffs | inhaled | hospitalization | 2023-03-20 | Patient admitted from ED for COPD exacerbation, started on nebulized bronchodilators and oxygen support. |
| V7K6ZQ1B | outpatient | 94 | blank | male | 2017-12-05 | blank | Asthma (pediatric) | 2022-03-09 | ENCOUNTER1005 | 2023-04-02T11:11:00 | PROV1011 | Cough and wheezing | 112 | 88 | 50 | 37 | 32 | Peak flow | 180 | L/min | Albuterol | 2 puffs | inhaled | blank | blank | Pediatric patient with moderate asthma exacerbation, responded to inhaled albuterol, no acute complications. |
| F3S2N7RL | outpatient | 98 | White | female | 1974-09-30 | Not Hispanic or Latino | Hypertension | 2015-06-12 | ENCOUNTER1006 | 2023-04-11T14:34:00 | PROV1102 | Hypertension management | 85 | 138 | 89 | 36.6 | 17 | Serum creatinine | 1 | mg/dL | Lisinopril | 20 mg | oral | blank | blank | Blood pressure slightly elevated, advised medication adherence and lifestyle changes, no acute symptoms. |
| Z8P3C6YD | outpatient | 97 | Native Hawaiian or Other Pacific Islander | male | 1988-06-21 | blank | Chronic kidney disease stage 3 | 2016-05-18 | ENCOUNTER1007 | 2023-02-19T09:23:00 | PROV1098 | CKD routine monitoring | 78 | 130 | 80 | 36.8 | 18 | eGFR | 48 | mL/min | Losartan | 50 mg | oral | blank | blank | CKD stage 3, kidney function stable, blood pressure well controlled, continue current regimen. |
| M2X5R4VL | telehealth | 98 | White | other | 2001-03-30 | Hispanic or Latino | Rheumatoid arthritis | 2017-12-06 | ENCOUNTER1008 | 2023-05-05T15:01:00 | blank | Joint pain check-in | 82 | 117 | 73 | 36.5 | 19 | blank | blank | blank | Methotrexate | 15 mg | oral | blank | blank | Telehealth session for joint pain, no new flares, continues on DMARD therapy, tolerating medication. |
| Y3JC7X2P | outpatient | 99 | Black or African American | female | 1959-05-11 | Not Hispanic or Latino | Osteoporosis | 2020-01-22 | ENCOUNTER1009 | 2023-02-25T08:55:00 | PROV1033 | Bone density screening | 68 | 126 | 70 | 36.4 | 17 | DEXA scan T-score | -2.9 | blank | Alendronate | 70 mg | oral | blank | blank | Osteoporosis confirmed, started bisphosphonate therapy, vitamin D supplementation recommended. |
| PK4W9C8S | emergency | 86 | blank | unknown | 1966-10-13 | blank | Hypertrophic cardiomyopathy | 2015-07-30 | ENCOUNTER1010 | 2023-03-28T16:18:00 | PROV1073 | Chest pain and palpitations | 155 | 140 | 98 | 37.6 | 27 | Troponin I | 0.9 | ng/mL | Metoprolol | 50 mg | oral | hospitalization | 2023-03-29 | Acute cardiac event, started on beta-blocker, admitted for observation and monitoring. |
| C2A7Q8NL | inpatient | 78 | blank | male | 2013-09-29 | blank | Cystic fibrosis | 2013-10-23 | ENCOUNTER1011 | 2023-02-20T10:09:00 | blank | Pulmonary exacerbation | 109 | 87 | 54 | 38.5 | 41 | Sweat chloride | 92 | mmol/L | Azithromycin | 250 mg | oral | complication | 2023-02-27 | Admitted for pulmonary infection, high fever and elevated RR, started on antibiotics, complication noted. |
| WG3N5V9B | outpatient | 96 | Asian | female | 1970-11-22 | blank | Type 2 diabetes mellitus | 2012-05-09 | ENCOUNTER1012 | 2023-04-09T12:45:00 | PROV1048 | Diabetes medication review | 89 | 124 | 76 | 37.1 | 17 | Hemoglobin A1c | 7.1 | % | Metformin | 1000 mg | oral | blank | blank | A1c slightly above target, medication dose increased, dietary counseling provided. |
| SO9D4R3X | outpatient | 97 | White | male | 1983-12-17 | Not Hispanic or Latino | Hypertension | 2020-10-19 | ENCOUNTER1013 | 2023-03-16T10:38:00 | PROV1083 | Elevated blood pressure | 95 | 142 | 91 | 36.9 | 16 | Serum potassium | 4.2 | mmol/L | Amlodipine | 5 mg | oral | blank | blank | Patient with newly diagnosed hypertension, started on calcium channel blocker, to monitor for side effects. |
| DU5T8Y6F | inpatient | 83 | blank | female | 1955-02-12 | blank | Chronic heart failure | 2017-09-25 | ENCOUNTER1014 | 2023-05-16T17:23:00 | PROV1101 | Shortness of breath | 102 | 110 | 58 | 37.8 | 29 | BNP | 1050 | pg/mL | Furosemide | 40 mg | IV | hospitalization | 2023-05-18 | Heart failure exacerbation, diuretic therapy initiated, close monitoring in inpatient setting. |
| G6L9S3XT | inpatient | 96 | blank | other | 2018-10-27 | blank | Spina bifida | 2018-10-28 | ENCOUNTER1015 | 2023-04-20T09:56:00 | blank | Routine post-op care | 128 | 86 | 45 | 37.5 | 38 | Electrolytes | 132 | mmol/L | Baclofen | 5 mg | oral | blank | blank | Pediatric patient recovering well from surgery, close parental involvement in care, no complications noted. |
| E9W5Z6KU | outpatient | 98 | White | female | 1962-01-13 | blank | Coronary artery disease | 2010-08-19 | ENCOUNTER1016 | 2023-05-21T13:25:00 | PROV1001 | Annual cardiac check-up | 76 | 129 | 69 | 36.3 | 15 | Lipid panel | 210 | mg/dL | Atorvastatin | 40 mg | oral | blank | blank | Stable angina with no recent symptoms, cholesterol slightly elevated, reinforcing medication adherence. |
| X1V7D5SM | telehealth | 99 | White | unknown | 1992-05-19 | Not Hispanic or Latino | Migraine disorder | 2016-04-20 | ENCOUNTER1017 | 2023-04-18T08:12:00 | blank | Migraine flare-up | 77 | 121 | 76 | 36.2 | 17 | blank | blank | blank | Sumatriptan | 50 mg | oral | blank | blank | Migraine attack discussed via telehealth, medication refilled, no new neurological symptoms. |
| UR8Y2X5N | outpatient | 99 | White | female | 1980-08-23 | Not Hispanic or Latino | Multiple sclerosis | 2013-10-10 | ENCOUNTER1018 | 2023-03-06T14:09:00 | PROV1061 | MS symptom review | 82 | 118 | 77 | 36.6 | 18 | Vitamin D | 32 | ng/mL | Interferon beta-1a | 44 mcg | subcutaneous | blank | blank | No new relapses, ambulatory, stable on disease-modifying therapy, vitamin D slightly low. |
| N7B1Q6TW | inpatient | 82 | Asian | female | 1953-02-14 | Hispanic or Latino | Chronic heart failure | 2018-01-10 | ENCOUNTER1019 | 2023-04-27T09:50:00 | PROV1027 | Heart failure exacerbation | 106 | 104 | 60 | 37.7 | 31 | BNP | 1350 | pg/mL | Furosemide | 40 mg | IV | hospitalization | 2023-04-29 | Heart failure symptoms worsened, IV diuresis provided, improvement noted prior to discharge. |
| PH9G4W1S | outpatient | 97 | White | male | 1987-07-09 | blank | Ulcerative colitis | 2012-06-16 | ENCOUNTER1020 | 2023-05-13T13:14:00 | PROV1059 | GI symptom management | 84 | 119 | 75 | 36.7 | 18 | CRP | 4.6 | mg/L | Mesalamine | 2.4 g | oral | blank | blank | Symptoms controlled on current regimen, inflammatory markers low, no evidence of flare. |
What the 200 rows show
from the 200-row sampleEmergency (encounter type) stands out: mean vital_
- 97median vital_
sign_ oxygen_ saturation - 2ethnicities
- 2outcome events
- 4genders
- 6medication routes
- 28lab test units
Median 97, from 78 to 99.
- string 16
- float 7
- date 3
- datetime 1
Columns
27 columns in three groups| column | type | description | example |
|---|---|---|---|
| Text 16 columns | |||
patient_id | string | Unique synthetic identifier for each patientunique | H4Q7T9ZC |
gender | string | Patient's gender identitymale · female · other · unknown | female |
race | string | Patient's self-identified race6 races · optional | White |
ethnicity | string | Patient's self-identified ethnicity2 ethnicities · optional | Not Hispanic or Latino |
chronic_condition | string | Primary chronic disease diagnosed for the patient | Alzheimer's disease |
encounter_id | string | Unique identifier for each patient encounter/visitunique | ENCOUNTER1001 |
encounter_type | string | Type of encounter (e.g., outpatient, inpatient, emergency, telehealth)outpatient · inpatient · emergency · telehealth · other | outpatient |
provider_id | string | Unique identifier for the healthcare provider seen during the encounteroptional | PROV1023 |
visit_reason | string | Chief complaint or reason for the visitoptional | Memory loss evaluation |
lab_test_name | string | Name of the laboratory test performed during the encounteroptional | Hemoglobin A1c |
lab_test_unit | string | Unit of measurement for the laboratory test resultoptional | % |
medication_name | string | Name of medication prescribed or administered during the encounteroptional | Donepezil |
medication_dose | string | Dose and unit of the medication (e.g., 10 mg)optional | 10 mg |
medication_route | string | Route of administration for the medication (e.g., oral, IV)6 routes · optional | oral |
outcome_event | string | Clinical outcome or event observed during or after the encounter (e.g., hospitalization, death, complication)2 events · optional | hospitalization |
notes | string | Free-text clinical notes or summary for the encounteroptional | Patient presented with on… |
| Numbers 7 columns | |||
vital_sign_heart_rate | float | Heart rate measured during the encounter (beats per minute)20 to 250 · optional | 71 |
vital_sign_systolic_bp | float | Systolic blood pressure measured during the encounter (mmHg)50 to 300 · optional | 122 |
vital_sign_diastolic_bp | float | Diastolic blood pressure measured during the encounter (mmHg)30 to 200 · optional | 74 |
vital_sign_temperature | float | Body temperature measured during the encounter (Celsius)30 to 45 · optional | 36.5 |
vital_sign_respiratory_rate | float | Respiratory rate measured during the encounter (breaths per minute)5 to 60 · optional | 16 |
vital_sign_oxygen_saturation | float | Oxygen saturation measured during the encounter (percentage)50 to 100 · optional | 97 |
lab_test_value | float | Result value of the laboratory testoptional | 5.4 |
| Dates and times 4 columns | |||
birth_date | date | Patient's date of birth | 1950-04-13 |
diagnosis_date | date | Date of initial chronic disease diagnosis | 2013-11-22 |
encounter_date | datetime | Date and time of the patient encounter | 2023-03-14T09:34:00 |
outcome_date | date | Date of the outcome event, if applicableoptional | 2023-02-10 |
Use it for
A healthcare dashboard
Vital_
sign_ oxygen_ saturation by encounter_ type and a breakdown of race. Excel, Power BI or Tableau. Why do the 16 emergency rows have a mean vital_
sign_ oxygen_ saturation of 84.4? A root-cause class exercise
Hand out the rows and one question. The answer is in the data, not in the brief.
- Patients200H4Q7T9ZC97outpatie…BD2W8R3L98outpatie…QZ8TM4KN96inpatient
A software demo
Believable patients with gender, birth_
date and race to fill a screen in front of a buyer.
blueprint · synthetic-patient-health-trajectories
Behind this dataset
Same schema. As many rows as you need.
These 200 rows came out of a blueprint — 27 columns with generation rules behind each one. Open it in Data Factory to retune a column, add your own, wire in foreign keys, and run it at the size you actually need.
- Each patient has at least three chronic condition codes
- Records span a minimum of 2 years per patient
- Includes synthetic demographic, lab, and medication data
- No patient identifier is reused
1 credit per row. New accounts start with 25 free credits.
- Exports
- CSV, JSON, JSONL, Parquet, SQL, Excel, TSV, XML
- Licence
- yours to use, including commercially
- API slug
- synthetic-patient-health-trajectories